Cibus, Inc. Class A (CBUS) Dividend History

Cibus, Inc. Class A (CBUS) is a biotechnology company focused on developing innovative gene-editing technologies for agriculture. They aim to create healthier, more sustainable crops through precise and efficient genetic modifications, helping to address global food security and environmental challenges.

6455 Nancy Ridge Drive, San Diego, CA, 92121
Phone: (858) 450-0008
Website: https://www.cibus.com

Dividend History

Cibus, Inc. Class A currently does not pay dividends

Company News

Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat

Cibus, a leading agricultural biotechnology company, announced that its Co-Founder, President, and Interim CEO participated in the BofA Securities 2025 AgTech Virtual Conference. The company discussed its gene editing platform, productivity trait pipeline, and recent regulatory developments supporting agricultural innovation.

GlobeNewswire Inc.
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call

Cibus, a leading agricultural biotechnology company, will report its first quarter 2025 financial results on May 8, 2025 and host a conference call to discuss the results and provide company updates.

GlobeNewswire Inc.
Cibus Announces Important Update to Rice Gene Editing Conversion Rates

Cibus, a leading agricultural technology company, has issued a correction regarding the rice conversion rates previously disclosed in its January 16, 2025 press release. The company has concluded that the gene editing conversion rates of 10-25% in Rice have not been reconfirmed based on subsequent experiments and high variability in the conversion rate data.

GlobeNewswire Inc.
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer

Totus Medicines, a company developing small molecule medicines using DNA-encoded covalent library technology and AI/ML, has appointed Simon Harnest as its new Chief Financial Officer. This appointment comes as the company prepares to advance its lead covalent PI3Kα inhibitor, TOS-358, following positive Phase 1 results.

GlobeNewswire Inc.

Featured Companies: MGX
Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola

Cibus, an agricultural technology company, announced that its next-generation herbicide tolerance (HT2) trait in canola has shown increased tolerance to a novel herbicide in greenhouse testing. This milestone paves the way for larger-scale field testing in 2025, as Cibus aims to provide farmers with additional weed control options.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 09:44:09 UTC